We are proud to share an important milestone for Aspivix and for carevix®, marking a significant step forward in evidence-based innovation in women’s health.
‎
The results of our Ambassador Program have now been officially published online in the International Journal of Gynecology & Obstetrics, one of the leading peer-reviewed journals in the field.
‎
Publication details
‎
Title: Safety and efficacy of a suction cervical stabilizer for IUD insertion: Results from a multicenter post-marketing study Journal: International Journal of Gynecology & Obstetrics
DOI: https://doi.org/10.1002/ijgo.70718
‎
Strengthening the clinical evidence behind carevix®
‎
This multicenter post-marketing study evaluated the safety and efficacy of a suction-based cervical stabilizer during IUD insertion. Its publication in a respected international journal further reinforces the growing body of clinical evidence supporting carevix® as a gentler, patient-centered alternative to traditional cervical stabilization methods.
‎
Importantly, this peer-reviewed research supports carevix®’s positioning as the first and only clinically proven suction-based cervical stabilizer, providing reassurance and confidence to clinicians integrating it into routine practice.
‎
Supporting clinicians, partners, and future growth
‎
Beyond its scientific significance, this publication represents strong validation for healthcare professionals, distribution partners, and health systems worldwide. It will play a key role in supporting ongoing and future commercial activities, educational initiatives, and broader adoption of carevix® across global markets.
‎
At Aspivix, we remain committed to advancing transcervical care through rigorous clinical research, meaningful collaboration with clinicians, and innovation that prioritizes patient comfort and safety. This publication is an important step forward in that journey—and we look forward to continuing to build the evidence that supports better care for women everywhere.